Bing Zou Selected Research

X-Linked Inhibitor of Apoptosis Protein

10/2012	Domain organization of XAF1 and the identification and characterization of XIAP(RING) -binding domain of XAF1.
9/2009	Adenovirus-mediated down-regulation of X-linked inhibitor of apoptosis protein inhibits colon cancer.
6/2009	Peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of Embelin on colon carcinogenesis.
2/2009	c-Jun N-terminal kinase (JNK1) upregulates XIAP-associated factor 1 (XAF1) through interferon regulatory factor 1 (IRF-1) in gastrointestinal cancer.
7/2008	Down-regulation of X-linked inhibitor of apoptosis synergistically enhanced peroxisome proliferator-activated receptor gamma ligand-induced growth inhibition in colon cancer.
6/2008	Loss of XIAP sensitizes rosiglitazone-induced growth inhibition of colon cancer in vivo.
3/2006	All-trans retinoic acid induces XAF1 expression through an interferon regulatory factor-1 element in colon cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bing Zou Research Topics

Disease

28	Neoplasms (Cancer) 01/2022 - 11/2003
14	Colonic Neoplasms (Colon Cancer) 01/2011 - 02/2005
6	Carcinogenesis 01/2011 - 11/2003
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 07/2019
4	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2011
4	Stomach Neoplasms (Stomach Cancer) 09/2010 - 11/2003
4	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 09/2009 - 09/2006
3	Hypoxia (Hypoxemia) 04/2022 - 10/2017
3	Infections 01/2021 - 09/2009
3	Inflammation (Inflammations) 11/2020 - 03/2009
2	Shock 04/2021 - 02/2006
2	Myocardial Infarction 01/2021 - 10/2016
2	Nonsyndromic Deafness 01/2020 - 01/2017
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020 - 01/2018
2	Carcinoma (Carcinomatosis) 01/2018 - 03/2006
2	Ulcer 01/2017 - 10/2015
2	Deafness (Deaf Mutism) 01/2017 - 01/2016
2	Myocardial Ischemia (Ischemic Heart Diseases) 10/2016 - 01/2015
1	Cardiac Arrhythmias (Arrythmia) 04/2022
1	Thymoma (Thymic Carcinoma) 01/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022
1	Pneumonia (Pneumonitis) 05/2021
1	Radiation Pneumonitis 05/2021
1	Esophagitis 05/2021
1	Nephrolithiasis 04/2021
1	Hypertension (High Blood Pressure) 04/2021
1	Urolithiasis 04/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 11/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Esophageal Fistula 01/2020
1	Sarcoidosis (Schaumann Disease) 01/2020
1	Esophageal Neoplasms (Esophageal Cancer) 01/2020
1	Brain Neoplasms (Brain Tumor) 01/2018
1	Starvation 10/2017
1	Alzheimer Disease (Alzheimer's Disease) 09/2017
1	Neurilemmoma (Schwannoma) 05/2017
1	Acoustic Neuroma (Acoustic Neurinoma) 05/2017
1	Peptic Ulcer (Peptic Ulcers) 01/2017

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 10/2017 - 03/2006
8	LigandsIBA 03/2010 - 06/2008
7	X-Linked Inhibitor of Apoptosis ProteinIBA 10/2012 - 03/2006
5	PPAR gammaIBA 06/2009 - 06/2008
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2018
3	Messenger RNA (mRNA)IBA 10/2017 - 03/2006
3	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 09/2010
3	SurvivinIBA 03/2010 - 11/2003
3	Troglitazone (Rezulin)FDA Link 09/2008 - 06/2008
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2021
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 11/2020 - 09/2009
2	Pharmaceutical PreparationsIBA 11/2020 - 10/2009
2	Phosphotransferases (Kinase)IBA 10/2017 - 09/2006
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2017 - 03/2006
2	Cadherins (E-Cadherin)IBA 01/2011 - 09/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2010 - 09/2009
2	Caspase 3 (Caspase-3)IBA 03/2010 - 09/2009
2	Therapeutic UsesIBA 09/2009 - 02/2005
2	Interferon Regulatory Factor-1 (Interferon Regulatory Factor 1)IBA 02/2009 - 03/2006
2	Rosiglitazone (Avandia)FDA Link 01/2009 - 06/2008
2	InterferonsIBA 02/2008 - 03/2006
1	LuciferasesIBA 04/2022
1	Competitive Endogenous RNAIBA 04/2022
1	Circular RNAIBA 04/2022
1	RNA Precursors (Precursor, mRNA)IBA 04/2022
1	anlotinibIBA 01/2022
1	Purinergic Receptors (Receptors, Purine)IBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	CateninsIBA 01/2021
1	Cytochrome P-450 CYP2C19IBA 01/2021
1	Methotrexate (Mexate)FDA LinkGeneric 11/2020
1	Benzene (Benzole)IBA 10/2020
1	ethylene dichloride (1,2-dichloroethane)IBA 10/2020
1	Ethylene Dibromide (1,2 Dibromoethane)IBA 10/2020
1	Chloroform (Trichloromethane)IBA 10/2020
1	Alkaline PhosphataseIBA 01/2020
1	Muscle Proteins (Muscle Protein)IBA 01/2020
1	Ribose-Phosphate Pyrophosphokinase (Phosphoribosyl Pyrophosphate Synthetase)IBA 01/2020
1	PlatinumIBA 01/2020
1	oxidized low density lipoproteinIBA 01/2020
1	AlbuminsIBA 01/2020
1	Carbonic Anhydrase IXIBA 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Carcinoembryonic AntigenIBA 01/2018
1	NADP (NADPH)IBA 10/2017
1	Glucose (Dextrose)FDA LinkGeneric 10/2017
1	Peptides (Polypeptides)IBA 09/2017
1	Amyloid (Amyloid Fibrils)IBA 09/2017
1	ponatinibIBA 05/2017
1	monooxyethylene trimethylolpropane tristearate (MTTS)IBA 01/2017
1	salicylhydroxamic acid (SHAM)IBA 10/2016

Therapy/Procedure

4	Radiotherapy 05/2021 - 07/2019
4	Therapeutics 04/2021 - 01/2009
2	Drug Therapy (Chemotherapy) 01/2020 - 07/2019
1	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 04/2021
1	Immunotherapy 01/2021
1	Pneumonectomy (Lung Volume Reduction) 01/2020
1	Chemoradiotherapy 07/2019
1	Cranial Irradiation 01/2018